Biotech Values

[biotech jim]

I thought we had already seen a BACE inhibitor in trials, LLYs Semagacestat and it was not so promising.

LLYs semagacestat is a gamma secretase inhibitor.

First in class generally refers to approved drugs, not to compounds in clinical trials.